» Articles » PMID: 29078389

Dominant Negative Effect of the Loss-of-function γ-secretase Mutants on the Wild-type Enzyme Through Heterooligomerization

Overview
Specialty Science
Date 2017 Oct 29
PMID 29078389
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

γ-secretase is an intramembrane protease complex consisting of nicastrin, presenilin-1/2, APH-1a/b, and Pen-2. Hydrolysis of the 99-residue transmembrane fragment of amyloid precursor protein (APP-C99) by γ-secretase produces β-amyloid (Aβ) peptides. Pathogenic mutations in and , which encode the catalytic subunit presenilin-1/2 of γ-secretase, lead to familial Alzheimer's disease in an autosomal dominant manner. However, the underlying mechanism of how the mutant gene may affect the function of the WT allele remains to be elucidated. Here we report that each of the loss-of-function γ-secretase variants that carries a mutation suppresses the protease activity of the WT γ-secretase on Aβ production. Each of these γ-secretase variants forms a stable oligomer with the WT γ-secretase in vitro in the presence of the detergent CHAPSO {3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate}, but not digitonin. Importantly, robust protease activity of γ-secretase is detectable in the presence of CHAPSO, but not digitonin. These experimental observations suggest a dominant negative effect of the γ-secretase, in which the protease activity of WT γ-secretase is suppressed by the loss-of-function γ-secretase variants through hetero-oligomerization. The relevance of this finding to the genesis of Alzheimer's disease is critically evaluated.

Citing Articles

Cortical neurodegeneration caused by mutations is independent of Aβ.

Yan K, Zhang C, Kang J, Montenegro P, Shen J Proc Natl Acad Sci U S A. 2024; 121(34):e2409343121.

PMID: 39136994 PMC: 11348310. DOI: 10.1073/pnas.2409343121.


Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival.

Kang J, Huang G, Ma L, Tong Y, Shahapal A, Chen P Elife. 2024; 12.

PMID: 38856715 PMC: 11164531. DOI: 10.7554/eLife.92673.


Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.

Area-Gomez E, Schon E J Alzheimers Dis. 2024; 98(4):1243-1275.

PMID: 38578892 PMC: 11091651. DOI: 10.3233/JAD-231318.


Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer's Disease and Other Neurodegenerative Diseases.

Sun Y, Islam S, Michikawa M, Zou K Int J Mol Sci. 2024; 25(3).

PMID: 38339035 PMC: 10855926. DOI: 10.3390/ijms25031757.


Lipophorin receptors genetically modulate neurodegeneration caused by reduction of Psn expression in the aging Drosophila brain.

Kang J, Zhang C, Wang Y, Peng J, Berger B, Perrimon N Genetics. 2023; 226(1.

PMID: 37996068 PMC: 10763532. DOI: 10.1093/genetics/iyad202.


References
1.
Sun L, Zhou R, Yang G, Shi Y . Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase. Proc Natl Acad Sci U S A. 2016; 114(4):E476-E485. PMC: 5278480. DOI: 10.1073/pnas.1618657114. View

2.
Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S . gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009; 29(41):13042-52. PMC: 6665297. DOI: 10.1523/JNEUROSCI.2362-09.2009. View

3.
Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

4.
Estus S, Golde T, Kunishita T, Blades D, Lowery D, Eisen M . Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science. 1992; 255(5045):726-8. DOI: 10.1126/science.1738846. View

5.
Shen J, Bronson R, Chen D, Xia W, Selkoe D, Tonegawa S . Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 1997; 89(4):629-39. DOI: 10.1016/s0092-8674(00)80244-5. View